SEC EDGAR 6-KNov 6$CRLBF

Cresco Labs Inc. (CRLBF): Financial results for Q3 2026

Cresco Labs Inc. (CRLBF) furnished an SEC Form 6-K — earnings release. Cresco Labs Exhibit 99.3 Page 1 of 8 Cresco Labs Reports Third Quarter 2026 Financial Results Delivers $173 Million in Revenue and $26 Million Operating Cash Flow CHICAGO – November 6, 2026 – Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”

Original reporting

SEC EDGAR 6-K

Published Nov 6, 2026, 12:34 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 6, 2026, 12:34 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$CRLBF

Neutral

high confidence

Mentioned

$CRLBF

Relevance

7/10

AlphAI data visualization · based on SEC EDGAR 6-K

Decision brief

The 30-second read

$CRLBFNeutralMed

Why it matters

The earnings release provides the first public disclosure of Q3 financials, offering traders fresh data to assess valuation and cash flow trends.

Market read

First‑report earnings for a mid‑cap cannabis company; modest revenue growth and cash flow may influence short‑term price action.

Timing

pre‑market today

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Cresco Labs, a cannabis producer listed on OTCQX (CRLBF), filed its Q3 2026 earnings via a SEC Form 6‑K.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CRLBFNeutralHigh confidence

Context

Q3 2026 earnings release reporting $173M revenue, $15M net loss and $26M operating cash flow.

Expected impact

potential modest move as market digests earnings and cash flow details

Evidence & confidence

First‑report earnings numbers provide fresh data; scale is modest, so impact is expected to be limited.

Key entities

company
Cresco Labs Inc.
Cannabis producer reporting Q3 2026 results.

Read at source ← All news

$CRLBFMed

Cresco Labs Reports Third Quarter 2026 Financial Results

Cresco Labs reported Q3 2026 revenue of $173M, gross profit of $79M, and operating cash flow of $26M. The company maintained its market-leading position and completed an acquisition. CEO Charlie Bachtell highlighted operational execution and preparedness for federal regulatory changes. The company had $76M in cash and $454M in long-term debt as of Q3 2026.

elliotlakestandard.caNov 6

Med

Cannabis company Cresco Labs generated $26 million in cash from operations, but lost $15 million.

Cresco Labs reported Q3 2026 revenue of $173 million, a gross profit of $79 million, and a net loss of $15 million. The company generated $26 million in operating cash flow. Management highlighted preparedness for federal regulatory changes. As of September 30, 2026, Cresco Labs had $454 million in cash and $76 million in long-term debt.

stocktitan.netNov 6

Med

Cresco Labs (CNSX:CL) Stock Turns Profitable But Margin Durability Remains Unclear

Simply Wall St reports Cresco Labs’ Q2 results shifted to profitability, with revenue of US$173.3m (vs. US$166.1m), net income of US$16.8m (vs. a US$16.3m loss), and basic EPS of US$0.045. Adjusted EBITDA was US$40m, with a 22.8% margin and 51.6% adjusted gross margin. Operating cash flow was US$15m vs capex US$9m, while management guided Q3 EBITDA margin near 20%.

simplywall.stAug 8

$CRLBFMed

Cresco Labs (OTCMKTS:CRLBF) Trading Up 3.6% – Still a Buy?

Cresco Labs Inc. (OTCMKTS:CRLBF) shares rose 3.6% to $0.9498 after trading as high as $0.98 on Monday; the article says 476,660 shares changed hands, down 31% from average volume. Zacks upgraded the stock from “strong sell” to “hold.” For the quarter ended May 8, EPS was -$0.04 vs -$0.03 estimate on revenue of $151.33M vs $148.58M.

tickerreport.comJun 2

$APPMed

AppLovin Jumps 8% as Post-Earnings Rally Extends; Unity Climbs 7%, Trade Desk Dips

AppLovin (APP) rose 8% to $386.05, extending a 31% post-earnings rally. Q3 2026 revenue hit $2.18B, up 55.5% YoY, beating estimates. The company forecast Q4 2026 revenue between $2.365B and $2.395B. Analysts raised price targets, with an average at $461.70. Unity (U) climbed 7%, while The Trade Desk (TTD) dipped 0.6%.

247wallst.comNov 6

$IONQMedAI 8/10

IonQ Surges 18% on Beat and Raised Guidance; Rigetti Computing Jumps 18%, D-Wave Quantum Surges 16%

IonQ (IONQ) reported Q3 2026 revenue of $173.8M, up 336% YoY, beating estimates. The company raised its 2026 revenue guidance to $505M-$515M. Despite growth, losses widened, and share count increased due to equity offerings. Rigetti (RGTI) and D-Wave (QBTS) stocks also surged on the news.